EC Ophthalmology

Editorial Volume 15 Issue 2 - 2024

Is there a Universal Drug for Keratitis?

Marianne L Shahsuvaryan*

Department of Ophthalmology, Yerevan State Medical University, Yerevan, Armenia

*Corresponding Author: Marianne L Shahsuvaryan, Department of Ophthalmology, Yerevan State Medical University, Yerevan, Armenia.
Received: December 01, 2023; Published: January 23, 2024



Keratitis represents the fifth most common cause of blindness worldwide [1] and a leading cause of irreversible visual impairment [2]. No age group is immune to it [3]. In the adult population older than 40 years 3.372 million suffered from moderate or severe deterioration of vision due to corneal opacity, as was estimated in 2020 by Wang., et al [4]. Early recognition and prompt treatment initiation are key to sight preserving in order to achieve the best outcomes in patients with keratitis.